A recent study has identified plasma metabolomic signatures in precancerous gastric lesions that progress to GC (Huang et al, 2021) and an extracellular vesicle-derived lncRNA GClnc1 has been proven to accurately differentiate between GC and gastric precancerous lesions (Guo et al, 2023). The gene discussed is SOD2; the disease is gastric cancer.